Implications of lymphatic mapping for staging and adjuvant treatment of patients with breast cancer

European Journal of Cancer

Volumn 40, Issue 2, 2004, Pages 179-181

  Nieweg, O E ^a   Bartelink, H ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Breast neoplasms; Chemotherapy, adjuvant; Diagnostic techniques and procedures; Hormone treatment; Neoplasm staging; Radiotherapy, adjuvant; Sentinel lymph node

Indexed keywords

ACCURACY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AXILLA; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC MAPPING; LYMPHOSCINTIGRAPHY; MEDICAL EXAMINATION; METASTASIS; METHODOLOGY; MORBIDITY; PATHOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; STANDARD; SURGEON; TECHNIQUE;

EID: 0347185030     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.09.026     Document Type: Article

References (25)

1. Kapteijn B.A.E., Nieweg O.E., Peterse J.L.et al. Identification and biopsy of the sentinel node in breast cancer. Eur. J. Surg. Oncol. 24:1998;427-430.
2. Cox C.E., Salud C.J., Harrinton M.A. The role of selective sentinel lymph node dissection in breast cancer. Surg. Clin. North Am. 80:2000;1759-1777.
3. Nieweg O.E., Estourgie S.H., Valdés Olmos R.A., Rutgers E.J.T., Hoefnagel C.A., Kroon B.B.R. Sentinel node biopsy with tracer administration into the primary breast cancer. Eur. J. Surg. Oncol. 29:2003;95-97.
4. Giuliano A.E., Haigh P.I., Brennan M.B.et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J. Clin. Oncol. 18:2000;2553-2559.
5. Roumen R.M., Kuijt G.P., Liem I.H., van Beek M.W. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br. J. Surg. 88:2001;1639-1643.
6. Guenther J.M. Dye-directed sentinel node biopsy for breast cancer. Ann. Surg. Oncol. 9(Suppl.):2002;S56. (abstr).
7. Torrenga H., Meijer S., Van der Sijp J.R.M. Recurrence after long terrm follow-up (>40 month) in 100 SN negative breast cancer patients. Eur. J. Surg. Oncol. 28:2002;304. (abstr).
8. Estourgie S.H., Nieweg O.E., Valdés Olmos R.A., Rutgers E.J., Peterse J.L., Kroon B.B.R. Eight false negative sentinel node procedures in breast cancer. what went wrong? Eur. J. Surg. Oncol. 29:2003;336-340.
9. Uren R.F., Howman-Giles R.B., Thompson J.F.et al. Mammary lymphoscintigraphy in breast cancer. J. Nucl. Med . 36:1995;1775-1780.
10. Byrd D.R., Dunnwald L.K., Mankoff D.A.et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann. Surg. Oncol. 8:2001;234-240.
11. Jansen L., Doting M.H.E., Rutgers E.J.T., de Vries J., Valdés Olmos R.A., Nieweg O.E. Clinical relevance of sentinel nodes outside the axilla in patients with breast cancer. Br. J. Surg. 87:2000;920-925.
12. Dupont E.L., Salud C.J., Peltz E.S.et al. Clinical relevance of internal mammary node mapping as a guide to radiation therapy. Am. J. Surg. 182:2001;321-324.
13. Borgstein P.J., Pijpers R., Comans E.F., van Diest P.J., Boom R.P., Meijer S. Sentinel lymph node biopsy in breast cancer. guidelines and pitfalls of lymphoscintigraphy and gamma probe detection J. Am. Coll. Surg. 186:1998;275-283.
14. Van der Ent F.W.C., Kengen R.A.M., Van der Poll H.A.G., Hoofwijk A.G.M. Sentinel node biopsy in 70 unselected patients with breast cancer. increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer Eur. J. Surg. Oncol. 25:1999;24-29.
15. Van der Ent F.W.C., Kengen R.A.M., Van der Poll H.A.G., Povel J.A.C.M., Stroeken H.J.G., Hoofwijk A.G.M. Halsted revisited. internal mammary sentinel lymph node biopsy in breast cancer Ann. Surg. 234:2001;79-84.
16. Estourgie S.H., Tanis P.J., Nieweg O.E.et al. Should the hunt for internal mammary chain sentinel nodes begin? Ann. Surg. Oncol. 10:2003;935-941.
17. Valdagni R., Amichetti M., Ciocca M. Patterns of radiotherapy for early breast cancer in Northern Italy compared with European and national standards. Radiother Oncol. 51:1999;79-85.
18. Paszat L.F., Mackillop W.J., Groome P.A., Boyd C., Schulze K., Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J. Clin. Oncol. 16:1998;2625-2631.
19. Hojris I., Overgaard M., Christensen J.J., Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy. analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group Lancet. 354:1999;1425-1430.
20. Veronesi U., Cascinelli N., Greco M.et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann. Surg. 202:1985;702-707.
21. Cody H.S. III, Urban J.A. Internal mammary node status. a major prognosticator in axillary node-negative breast cancer Ann. Surg. Oncol. 2:1995;32-37.
22. Estourgie S.H., Nieweg O.E., Valdés Olmos R.A., Hoefnagel C.A., Kroon B.B.R. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann. Surg. Oncol. 10:2003;681-688.
23. Van de Vijver M.J., He Y.D., van't Veer L.J.et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347:2002;1999-2009.
24. Nieweg O.E. A response to Lee M. Ellis's editorial. a perspective on sentinel lymph node biopsy in colorectal cancer: the race between surgical technology and molecular oncology Ann. Surg. Oncol. 8:2001;271.
25. Greene F.L., Page D.L., Fleming I.D.et al. AJCC Cancer Staging Manual. 6th edn. 2002;Springer, New York.